These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8093729)

  • 1. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.
    Stevens CW; Monasky MS; Yaksh TL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):63-70. PubMed ID: 2891846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat.
    Dunbar SA; Yaksh TL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1219-25. PubMed ID: 9190856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats.
    Graham BA; Hammond DL; Proudfit HK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):511-9. PubMed ID: 9353364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intrathecally administered imiloxan and WB4101: possible role of alpha 2-adrenoceptor subtypes in the spinal cord.
    Takano Y; Takano M; Yaksh TL
    Eur J Pharmacol; 1992 Sep; 219(3):465-8. PubMed ID: 1358645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians.
    Brenner GM; Klopp AJ; Deason LL; Stevens CW
    J Pharmacol Exp Ther; 1994 Aug; 270(2):540-5. PubMed ID: 7915313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli.
    Saeki S; Yaksh TL
    J Pharmacol Exp Ther; 1992 Feb; 260(2):795-802. PubMed ID: 1346645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Oct; 251(1):216-23. PubMed ID: 2795458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
    Monasky MS; Zinsmeister AR; Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):383-92. PubMed ID: 1974633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat.
    Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH; Roques BP
    J Pharmacol Exp Ther; 1993 May; 265(2):551-8. PubMed ID: 8098759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):1-8. PubMed ID: 2526212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep.
    Detweiler DJ; Eisenach JC; Tong C; Jackson C
    J Pharmacol Exp Ther; 1993 May; 265(2):536-42. PubMed ID: 8098758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions between two alpha(2)-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats.
    Graham BA; Hammond DL; Proudfit HK
    Pain; 2000 Mar; 85(1-2):135-43. PubMed ID: 10692612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
    Schwinn DA; Correa-Sales C; Page SO; Maze M
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal St-587: effects on nociceptive reflexes and blood pressure in the rat.
    Loomis CW; Arunachalam KD
    J Pharmacol Exp Ther; 1992 Nov; 263(2):428-35. PubMed ID: 1331398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.